HGEN

Stock ticker:
NASDAQ

67 days until earnings call

Intraday data for

Jan 21, 09:40 AM (EST)

Price

$2.63

Change

+$0.02 (+0.77%)

Capitalization

$166.6m

HGEN Price Prediction, Humanigen Stock Technical Analysis

Industry @Biotechnology

View Trends for HGEN(TRY FOR FREE)

Paper trades

Copy to...

Stock ticker: NASDAQ

HGEN

AS OF

Jan 21, 09:40 AM (EST)

Price

$2.63

Change

+$0.02 (+0.77%)

Capitalization

$166.6m

67 days until earnings call

HGEN Price Prediction, Humanigen Stock Technical Analysis

Stock market charts, price targets, analyst ratings and a financial calendar

Industry @Biotechnology

View Trends for HGEN(TRY FOR FREE)

Paper trades

Copy to...

A.I.dvisor published

HGEN Commentaries and news forecasts

3:00 PM EST Jan 20

REAL
TIME

HGEN (Humanigen): Weekly Commentary

Please wait a moment while the chart loads...

An error occurred while loading prices!

These past five trading days, the stock lost -7.75% with an average daily volume of 80851 shares traded. The stock tracked a drawdown of -10.0% for this period.

Please wait a moment while the chart loads...

An error occurred while loading prices!

AI Screener Basics

Expand

AI Screener FA & TA

Expand

Forecasts, Signals and Predictions about HGEN (Humanigen)

Technical Analysis	# Of Indicators	Avg. Odds
Bullish trend Bullish trend
Bearish trend Bearish trend
Bearish trend
Bullish trend

Fundamental Analysis	(1 - best, 100 - worst)

+320%

Swing Trader Crypto (ALGO, IOST, LINK, QTUM, NEO)

384 days traded

+76%

Trend Traders (Market Cap 2B-10B)

271 days traded

+76%

Trend is Your Friend(High Capitalization)

410 days traded

A.I.dvisor published

a Summary for HGEN with price predictions.

4:00 PM EST Jan 20

HGEN in -2.97% downward trend, sliding for three consecutive days on January 20, 2022

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where HGEN declined for three days, in of 94 cases, the price declined further within the following month. The odds of a continued downward trend are .

Current price $2.63 crossed the support line at $4.22 and is trading between $4.22 support and $-10.01 support lines. Throughout the month of 12/17/21 - 01/20/22, the price experienced a -41% Downtrend. During the week of 01/12/22 - 01/20/22, the stock fell -13%.

A.I.dvisor published

Humanigen Earnings Data

HGEN is expected to report earnings to fall 42.31% to -64 cents per share on March 29

Q4'21

Est.

$-0.65

Q3'21

Missed

by $0.14

Q2'21

Missed

by $0.34

Q1'21

Missed

by $0.61

Q4'20

Beat

by $0.04

The last earnings report on November 12 showed earnings per share of -112 cents, missing the estimate of -98 cents. With 43.79K shares outstanding, the current market capitalization sits at 166.57M.

Address	533 Airport Boulevard, Burlingame, CA, 94005
Phone	+1 650 243-3100
Employees	10
Web	https://www.humanigen.com

Capitalization Capitalization	167M
P/E Ratio P/E Ratio	N/A
Risk (Beta) Risk (Beta)	-3.39
Dividend Yield Dividend Yield	N/A
Total Cash Total Cash	121M
Total Cash/Share Total Cash/Share	1.89
Total Debt Total Debt	24.6M
Total Debt/Equity Total Debt/Equity	N/A
Projected Growth (PEG Ratio) Projected Growth (PEG Ratio)	N/A
Revenue/Share (as % of the share price) Revenue/Share (as % of the share price)	0%
Revenue Revenue	1.834M
ROE ROE	N/A
Book Value Book Value	43.7M
P/B Ratio P/B Ratio	8.83
Cash Flow Cash Flow	N/A
Earnings Earnings	-3.870
Average Daily Volume YTD Average Daily Volume YTD	N/A
Common Shares Outstanding - Security Level Common Shares Outstanding - Security Level	59K
Current Ratio Current Ratio	2.42
Current Revenue Per Employee Current Revenue Per Employee	103,600.00
Dividends Per Share - Security Dividends Per Share - Security	N/A
EBITDA EBITDA	-198,648,000
Float Float	N/A
Float - Current Float - Current	N/A
Gross Income Margin Gross Income Margin	100.00
Revenue To Assets Revenue To Assets	-242.75
Shares Held By Institutions Shares Held By Institutions	408M
Shares Outstanding - Current Shares Outstanding - Current	N/A
Total Liabilities Total Liabilities	78M
Total Volume MTD Total Volume MTD	N/A
Value	Under
Gain YTD	-29.839

Group	Domestic Stock Funds
Category	Biotechnology
Total Expense Ratio Total Expense Ratio
Min. Initial Investment Min. Initial Investment	0.00 USD
Fund Existence Fund Existence	a few seconds ago
Turnover Turnover
Front Load Front Load
Net Assets Net Assets	0.00 USD
Manager Tenure Manager Tenure

Group	Domestic Stock Funds
Category	Biotechnology
Capitalization Capitalization	166.57m USD
P/E Ratio P/E Ratio	N/A
Total Cash Total Cash	120.54m USD
Projected Growth Projected Growth	N/A
Total Debt Total Debt	24.63m USD
Revenue Revenue	1.83m USD
Risk (Beta) Risk (Beta)	-3.39
Dividend Yield Dividend Yield	N/A
Total Cash/Share Total Cash/Share	1.89
Total Debt/Equity Total Debt/Equity	N/A
Revenue/Share Revenue/Share	0.00USD	as % of share price

Group	Domestic Stock Funds
Category	Biotechnology
Net Assets Net Assets	0.00 USD
Fund Existence Fund Existence	a few seconds ago
Turnover Turnover
Capitalization Capitalization
Yield Yield
Total Expense Ratio Total Expense Ratio
Investment Style Investment Style
Risk (Beta) Risk (Beta)

Group	Domestic Stock Funds
Category	Biotechnology
Market Capitalization	0.00 USD
Volume	0.00 USD

A.I.dvisor

published a Pattern (end of day)

A.I.dvisor indicates that over the last year, HGEN has been loosely correlated with XBI. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if HGEN jumps, then XBI could also see price increases.

Real Time

TICKER / NAME	CORRELATION TO HGEN	1D PRICE CHANGE %
HGEN	100%	+0.77%
XBI - HGEN	35% Loosely correlated	-0.07%
LABU - HGEN	34% Loosely correlated	-0.26%
BTEC - HGEN	32% Poorly correlated	+0.64%
IDNA - HGEN	31% Poorly correlated	+0.62%
GINN - HGEN	28% Poorly correlated	-0.63%

Related Tickers to HGEN

Real Time

TICKER / NAME	PRICE	CHG	CHG %
		1 Day
BTEC	39.18	0.25	+0.64%
Principal Healthcare Innovators ETF
IDNA	35.6	0.22	+0.62%
iShares Genomics Immnlgy & Hlthcr ETF
XBI	91.84	-0.06	-0.07%
SPDR® S&P Biotech ETF
LABU	19.01	-0.05	-0.26%
Direxion Daily S&P Biotech Bull 3X ETF
CDMO	18.27	-0.24	-1.30%
Avid Bioservices

A.I.dvisor tells us that HGEN and CDMO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HGEN and CDMO's prices will move in lockstep.

Real Time

TICKER / NAME	CORRELATION TO HGEN	1D PRICE CHANGE %
HGEN	100%	+0.77%
CDMO - HGEN	31% Poorly correlated	-1.30%
EIGR - HGEN	29% Poorly correlated	-0.72%
VCYT - HGEN	29% Poorly correlated	+3.54%
GTHX - HGEN	28% Poorly correlated	+3.00%
GBT - HGEN	28% Poorly correlated	-0.60%

HGEN Price Prediction, Humanigen Stock Technical Analysis

Stock market charts, price targets, analyst ratings and a financial calendar

HGEN (Humanigen): Weekly Commentary

Forecasts, Signals and Predictions about HGEN (Humanigen)

HGEN in -2.97% downward trend, sliding for three consecutive days on January 20, 2022

Technical Analysis, Outlook, Fundamental Analysis READ MORE...

HGEN is expected to report earnings to fall 42.31% to -64 cents per share on March 29

General Information

Select Stock attributes to show

1 Day

HGEN (Humanigen): Weekly Commentary

Forecasts, Signals and Predictions about HGEN (Humanigen)

Technical Analysis, Outlook, Fundamental Analysis READ MORE...

General Information

Select Stock attributes to show

HGEN: pattern detected on

1 Day